Toll Free: 1-888-928-9744

GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update

Published: Jun 8, 2016 | Pages: 41 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

GenMark Diagnostics, Inc. (GenMark) is a medical device company that offers clinical testing solutions. The company's products include XT-8 systems and assays. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor 3A4/3A5 genotyping test, eSensor HCV genotyping test and eSensor HCVg direct test. GenMark develops products in the areas of genetics, pharmacogenetics, infectious disease and oncology. The company provides educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It has operations in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company GenMark Diagnostics, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 6 GenMark Diagnostics, Inc. Company Snapshot 7 GenMark Diagnostics, Inc. Company Overview 7 GenMark Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 8 GenMark Diagnostics, Inc.- Pipeline Analysis Overview 10 Key Facts 10 GenMark Diagnostics, Inc. - Major Products and Services 11 GenMark Diagnostics, Inc. Pipeline Products by Development Stage 12 GenMark Diagnostics, Inc. Pipeline Products Overview 14 2D6 Tamoxifen Metabolism Test 14 2D6 Tamoxifen Metabolism Test Product Overview 14 ePlex - Central Nervous System Infection Panel 15 ePlex - Central Nervous System Infection Panel Product Overview 15 ePlex System 16 ePlex System Product Overview 16 ePlex System - Fungal Infection Panel 17 ePlex System - Fungal Infection Panel Product Overview 17 ePlex System - Gastro Intestinal Test Panel 18 ePlex System - Gastro Intestinal Test Panel Product Overview 18 ePlex System - Gram Negative Bacterial Test 19 ePlex System - Gram Negative Bacterial Test Product Overview 19 ePlex System - Gram Positive Bacterial Test 20 ePlex System - Gram Positive Bacterial Test Product Overview 20 ePlex System - HCV Genotyping Test 21 ePlex System - HCV Genotyping Test Product Overview 21 ePlex System - RVP Test 22 ePlex System - RVP Test Product Overview 22 eSensor 2C19 Genotyping Test 23 eSensor 2C19 Genotyping Test Product Overview 23 eSensor 3A4/3A5 Genotyping Test 24 eSensor 3A4/3A5 Genotyping Test Product Overview 24 eSensor HCV Genotyping Test 25 eSensor HCV Genotyping Test Product Overview 25 eSensor HCVg Direct Test 26 eSensor HCVg Direct Test Product Overview 26 eSensor KRAS Test 27 eSensor KRAS Test Product Overview 27 Fully Integrated In-Vitro Diagnostic Platform 28 Fully Integrated In-Vitro Diagnostic Platform Product Overview 28 XT-8 System - Cancer Assay 29 XT-8 System - Cancer Assay Product Overview 29 XT-8 System - Genetic Diseases Assay 30 XT-8 System - Genetic Diseases Assay Product Overview 30 XT-8 System - Infectious Diseases Assay 31 XT-8 System - Infectious Diseases Assay Product Overview 31 XT-8 System - Pharmacogenetics Assay 32 XT-8 System - Pharmacogenetics Assay Product Overview 32 GenMark Diagnostics, Inc. - Key Competitors 33 GenMark Diagnostics, Inc. - Key Employees 34 GenMark Diagnostics, Inc. - Locations And Subsidiaries 35 Head Office 35 Recent Developments 36 GenMark Diagnostics, Inc., Recent Developments 36 May 03, 2016: GenMark Reports First Quarter 2016 Results 36 Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results 36 Jan 12, 2016: GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex Analytical Studies 37 Oct 27, 2015: GenMark Diagnostics Reports Q3 Financial Results 37 Aug 06, 2015: GenMark Diagnostics Reports Q2 Financial Results 37 May 05, 2015: GenMark Diagnostics Reports Q1 Financial Results 38 Apr 16, 2015: GenMark Announces Positive Preliminary Q1 Financial Results and ePlex Update 39 Apr 16, 2015: GenMark Announces ePlex Update 39 Feb 24, 2015: GenMark Reports Fourth Quarter and Full Year 2014 Results 39 Feb 23, 2015: GenMark Announces Appointment of New Board Members 40 Appendix 41 Methodology 41 About GlobalData 41 Contact Us 41 Disclaimer 41
List of Tables
GenMark Diagnostics, Inc. Pipeline Products and Clinical Trials Overview 8 GenMark Diagnostics, Inc. Pipeline Products by Equipment Type 8 GenMark Diagnostics, Inc. Pipeline Products by Indication 9 GenMark Diagnostics, Inc., Key Facts 10 GenMark Diagnostics, Inc., Major Products and Services 11 GenMark Diagnostics, Inc. Number of Pipeline Products by Development Stage 12 GenMark Diagnostics, Inc. Pipeline Products Summary by Development Stage 13 2D6 Tamoxifen Metabolism Test - Product Status 14 2D6 Tamoxifen Metabolism Test - Product Description 14 ePlex - Central Nervous System Infection Panel - Product Status 15 ePlex - Central Nervous System Infection Panel - Product Description 15 ePlex System - Product Status 16 ePlex System - Product Description 16 ePlex System - Fungal Infection Panel - Product Status 17 ePlex System - Fungal Infection Panel - Product Description 17 ePlex System - Gastro Intestinal Test Panel - Product Status 18 ePlex System - Gastro Intestinal Test Panel - Product Description 18 ePlex System - Gram Negative Bacterial Test - Product Status 19 ePlex System - Gram Negative Bacterial Test - Product Description 19 ePlex System - Gram Positive Bacterial Test - Product Status 20 ePlex System - Gram Positive Bacterial Test - Product Description 20 ePlex System - HCV Genotyping Test - Product Status 21 ePlex System - HCV Genotyping Test - Product Description 21 ePlex System - RVP Test - Product Status 22 ePlex System - RVP Test - Product Description 22 eSensor 2C19 Genotyping Test - Product Status 23 eSensor 2C19 Genotyping Test - Product Description 23 eSensor 3A4/3A5 Genotyping Test - Product Status 24 eSensor 3A4/3A5 Genotyping Test - Product Description 24 eSensor HCV Genotyping Test - Product Status 25 eSensor HCV Genotyping Test - Product Description 25 eSensor HCVg Direct Test - Product Status 26 eSensor HCVg Direct Test - Product Description 26 eSensor KRAS Test - Product Status 27 eSensor KRAS Test - Product Description 27 Fully Integrated In-Vitro Diagnostic Platform - Product Status 28 Fully Integrated In-Vitro Diagnostic Platform - Product Description 28 XT-8 System - Cancer Assay - Product Status 29 XT-8 System - Cancer Assay - Product Description 29 XT-8 System - Genetic Diseases Assay - Product Status 30 XT-8 System - Genetic Diseases Assay - Product Description 30 XT-8 System - Infectious Diseases Assay - Product Status 31 XT-8 System - Infectious Diseases Assay - Product Description 31 XT-8 System - Pharmacogenetics Assay - Product Status 32 XT-8 System - Pharmacogenetics Assay - Product Description 32 GenMark Diagnostics, Inc., Key Employees 34


List of Figures
GenMark Diagnostics, Inc. Pipeline Products by Equipment Type 9 GenMark Diagnostics, Inc. Pipeline Products by Development Stage 12

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global non halogenated flame retardants market size is anticipated to be valued at USD 2.54 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing safety materials demand owing to low heat & smoke emission properties in c

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify